The objective of this article is to derive a more accurate and easy-to-use formula for finding estimated standard liver volume (ESLV) using novel computed tomography (CT) measurement parameters. New formulas for ESLV have been emerging that aim to improve the accuracy of estimation. However, many of these formulas contain body surface area measurements and logarithms in the equations that lead to a more complicated calculation. In addition, substantial errors in ESLV using these old formulas have been shown. An improved version of the formula for ESLV is needed. This is a retrospective cohort of consecutive living donor liver transplantations from 2005 to 2016. Donors were randomly assigned to either the formula derivation or validation groups. Total liver volume (TLV) measured by CT was used as the reference for a linear regression analysis against various patient factors. The derived formula was compared with the existing formulas. There were 722 patients (197 from the derivation group, 164 from the validation group, and 361 from the recipient group) involved in the study. The donor's body weight (odds ratio [OR], 10.42; 95% confidence interval [CI], 7.25-13.60; P < 0.01) and body thickness (OR, 2.00; 95% CI, 0.36-3.65; P 5 0.02) were found to be independent factors for the TLV calculation. A formula for TLV (cm 3 ) was derived: 2 3 thickness (mm) 1 10 3 weight (kg) 1 190 with R 2 0.48, which was the highest when compared with the 4 other most often cited formulas. This formula remained superior to other published formulas in the validation set analysis (R 2 , 5.37; interclass correlation coefficient, 0.74). Graft weight/ESLV values calculated by the new formula were shown to have the highest correlation with delayed graft function (C-statistic, 0.79; 95% CI, 0.69-0.90; P < 0.01). The new formula (2 3 thickness 1 10 3 weight 1 190) represents the first study proposing the use of CT-measured body thickness which is novel, easy to use, and the most accurate for ESLV.
Precise estimated standard liver volume (ESLV) is of vital importance in decision making for major hepatectomies, living donor liver transplantations (LDLTs), and split-graft deceased donor liver transplantations (DDLTs). There are at least 14 formulas published for ESLV, (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) and a majority of them incorporated the patient's anthropometric parameters, such as body weight (BW) and height, body surface area (BSA), and body mass index (BMI), together with age and sex as the components of the equation. The abundance of these formulas suggested that no single formula has been universally accepted. During the workup stage for LDLT in our center, liver graft weight (GW) was calculated by a computed tomography (CT) volumetric study using the Heymsfield method, (15) and the GW/ESLV of the potential recipient was then determined.
small-for-size syndrome (SFSS), their use should be avoided. (16, 17) that are potentially fatal, then such LDLTs should be avoided. The crucial role of ESLV in LDLT has made it an area of research interest. Recent publications from the Asan group (18) evaluated the performance of some published standard liver volume (SLV) formulas (1) (2) (3) (4) (5) (6) (7) (8) 11) ; the mean percentage differences of SLV estimation were found to range from -3.9% to 1 65.3%. (18) Therefore, an accurate formula for ESLV with a small margin of error is eagerly awaited, setting the stage for the development of a newer formula.
In recent years, some new parameters for the SLV formula have been explored. Tongyoo et al. proposed using portal vein diameter measurements to calculate the liver volume. (19) However, the use of bedside ultrasonographic measurement is inevitably subject to interobserver variability; portal vein diameter could be unreliable especially in pathological situations and is not applicable to patients with cirrhosis, portal hypertension, or portal vein thrombosis. Moreover, there was no internal nor external validation in that particular study. Another novel parameter is known as the thoracic width, which was introduced by Kokudo et al. (14) In their proposed formula, a simple measurement of the distance between the bilateral costophrenic angle together with the patient's age and ethnicity were involved. It was claimed to be the most accurate and does not use BW for calculation. Nonetheless, pleural effusion and asymmetric diaphragm levels are fairly common in patients with chronic liver disease, which potentially limits its applicability, and the results of their study require external validation.
The use of CT-measured parameters as a component of the SLV formula has not been reported. Cross-sectional imaging such as CT is a prerequisite for both donors and transplant recipients nowadays, and it is possible to explore new parameters measurable only by a CT scan. This study investigates the role of novel CT measurements in ESLV and improves the accuracy of liver volume estimation using a new formula. This is the first study to report the use of body thickness as a parameter for the calculation of ESLV.
Patients and Methods
Consecutive pairs of adult-to-adult LDLTs were extracted from the liver transplantation (LT) database between 2005 and 2016. DDLTs and LDLTs involved the use of left lateral sectional grafts, subsectional grafts, and dual grafts; domino LDLT and pediatric recipients were excluded. Patients with incomplete medical records and donors without preoperative CT film for review were also excluded from the analysis. Demographic data, anthropometric parameters, radiological measurements, graft information, and postoperative outcomes were retrieved and analyzed. In this study, living donors were randomly allocated to a formula derivation group and a validation group in a 50:50 ratio by the statistical software. The whole study was composed of 3 parts, namely, formula derivation, formula validation, and formula validation using transplant recipient data. In part 1, demographic data, anthropometric parameters, and CT measurements were tested against the total liver volume (TLV) using a univariate analysis. Factors found to have significant association (P 0.05) were put into a multiple linear regression model for analysis. Independent parameters were used to formulate the equation of SLV. This formula was then validated and compared with other published SLV formulas in part 2 using the donor data from the validation group. In the third part of the study, the validated formula was used to calculate the GW/ESLV of each recipient. Because a small-for-size graft (SFSG) is the prerequisite for development of SFSS, we hypothesize that the accuracy of the formula is reflected by the association between GW/ESLV and the occurrence of SFSS. Because SFSS is the constellation of prolonged cholestasis, then prothrombin time, the presence of encephalopathy and refractory ascites, and universally accepted clinical, biochemical, and temporal cutoff values for its diagnosis are lacking and vary between series. (16, 17, 20, 21) A well-defined and objectively accessible SFSS surrogate is needed for outcome analysis in this part of the study. Therefore, in this article, we used delayed graft function (DGF) as a SFSS surrogate that was biochemically defined as total standard liver volume; T12, 12th thoracic spine; TLV, total liver volume.
bilirubin of 70 mmol/L or above and an international normalized ratio of 1.5 or above on postoperative day 5 after exclusion of other potentially attributable causes such as sepsis, vascular complications, and biliary obstruction.
DEFINITION OF BODY THICKNESS AND WIDTH
Preoperative CT films of all patients were retrieved and reviewed; 2 new CT parameters were under investigation in the current study, namely, body thickness and body width. Body thickness was defined as the shortest length between the linea alba and the tip of the twelfth thoracic vertebra (T12) spinous process. Body width was defined as the length of the imaginary line joining the left and right ends of the inner surface of the ribcage that is perpendicular to the line of body thickness and tangential to the anterior surface of the T12 vertebral body. In order to minimize interobserver variability, all measurements must be taken at the T12 body level. This anatomical landmark could be traced on the CT scan by following the 12th rib (T12 vertebrae is the last rib-bearing vertebra). The measurement occurred when the articulating facet between the T12 body and the head of the 12th rib came into view (Fig.  1) . The distance between the left and right costophrenic angle as described by Kokudo et al. (14) was also recorded. As a part of the liver donor workup protocol, CT volumetry was performed by an experienced radiologist using computer software, and the TLV (calculated in cm 3 ) was used for formula derivation and validation.
STATISTICAL ANALYSIS
Continuous variables were described as median (interquartile range [IQR] ). Categorical variables were analyzed using chi-square test or Fisher's exact test where appropriate. Variables with P value 0.05 in a simple linear regression were considered significant. The odds ratio (OR) of each independent parameter and the constant value from a multiple logistic regression analysis were used to formulate the new equation. This equation was validated and compared with the 4 other most often cited formulas in the literature.
(1,2,4,8) The performance of each formula was tested by a simple scatterplot together with the R 2 linear value. A reliability analysis was performed for each formula, and the accuracy was compared with the interclass correlation coefficient (ICC) in both the derivation and validation groups. In the third part of the study, the receiver operating characteristic (ROC) curves of GW/ESLV with respect to the occurrence of DGF were generated, and the corresponding area under the curve (AUC) was compared for each formula. SPSS, version 24.0 (IBM, Armonk, NY) was used for all statistical analysis.
ETHICS AND DECLARATIONS
This study does not require ethics board review according to local guidelines. All patient identities and clinical information were kept confidential.
Results

PATIENT POPULATION AND BASELINE CHARACTERISTICS
There were 722 patients (340 right lobe, 20 left lobe, 1 right posterior section donors, and 361 recipients) eligible for analysis (Fig. 2) . The majority of the donors were female, and the median age was 33 years old (IQR, 16.5 years). A right lobe liver with the middle hepatic vein (MHV) was the predominant graft type, and the median GW was 590 g (IQR, 147.5 g) during back-table measurement. The median length of hospital stay for donors was 7 days (IQR, 3 days), and there was no hospital mortality for donor hepatectomies within the study period. The median age of the recipients was 54 years old (IQR, 11 years), and white male NOTE: Data are given as n (%) or median (IQR). (Tables 1 and 2 ). The performance of the existing formulas in terms of percentage difference ([ESLV -CT-measured liver volume]/CT measured volume 3 100%) and the standard error of mean of each formula are given (Table 3) .
PART 1: FORMULA DEVELOPMENT
After randomization, there were 197 donors in the derivation groups. No heterogeneity was observed between the derivation and validation populations (Table 4) . Apart from the donor age, all the other factors were significantly associated (P < 0.05) with the TLV of the donor (Table 5 ). These factors were analyzed using a multiple linear regression model. Donor BW (OR, 10.42; 95% confidence interval [CI], 7.25-13.60; P < 0.01) and body thickness (OR, 2.00; 95% CI, 0.36-3.65; P 5 0.02) were found to be the independent factors associated with TLV. A formula for TLV was derived as 2 3 thickness (mm) 1 10 3 weight (kg) 1 190 with an R 2 of 0.48, which was the highest when compared with other formulas (Fig.  3A-E) . The derived formula was also shown to have a very high ICC value of 0.79 (95% CI, 0.72-0.84; P < 0.01) after the reliability analysis, suggesting that it has the best correlation with the TLV of the donors in the derivation group. 
PART 2: FORMULA VALIDATION
In the validation group, there were 164 patients, and the ESLVs of the patients were calculated using the derived formulas and the other 4 formulas. The R 2 and ICC values of the derived formula were 0.54 (Fig. 4A-E) and 0.74, respectively, which were the highest compared with the other formulas (Table 6 ).
PART 3: FORMULA VALIDATION BY TRANSPLANT RECIPIENT
In the 361 LDLT recipients, biochemical features of DGF were observed in 40 (11.1%) patients after exclusion of secondary causes such as intra-abdominal collection, ongoing sepsis, bile duct obstructions, and vascular complications. A total of 7 out of these 40 patients had graft failure: 2 were retransplanted and 5 eventually died. Preoperative CT scans were available for analysis in 257 patients. ROC curves of GW/ ESLV in relation to DGF using different formulas were generated. The AUC of the new formula was 0.79 (95% CI, 0.69-0.90; P < 0.01), which is the highest when compared with the rest of the formulas and with the graft-to-recipient weight ratio (GRWR; Fig.  5A-F) . 
Discussion
This study represents the first and largest series deriving and validating a SLV formula using liver donors and transplant recipients. Although many of the demographic and anthropometric factors showed significant association with TLV, body thickness and weight stood out as the only 2 independent parameters of TLV. Other versions of derived formulas that did not contain BW as a parameter for calculation in the present series had significantly worse correlation than the formulas that had BW as one of the calculated components (results not shown). This probably explained why BW had to be incorporated in most of the published formulas: to achieve a good correlation with TLV. The authors believed that BW is a highly important and reliable factor in the calculation of SLV in normal individuals and patients with cirrhosis provided that BW was taken after the drainage of ascetic fluid.
Since the first report by Yonemura et al. that liver graft volume was significantly overestimated in patients younger than 30 years old, (22) age has been considered to be an influential factor for liver volume estimation. The use of age-adjusted formulas has been advocated in order to improve the accuracy of CT volumetric assessment of young liver grafts. (23) However, independent association between age and liver volume could not be demonstrated in the present series. The association between donor age and liver volume is probably not as strong as the other anthropometric factors as echoed by the fact that most of the other published SLV formulas from different ethnicities did not include age as a function of liver volume estimation.
(1-5,7-10,12,13) From our experience, overestimation of graft size is more likely in teenagers and patients in their early 20s. Because the median age of the donors in the present series was 33 years, the subtle effect of young age on liver volume estimation might not be apparent. A linear regression model has been the method used for formula deduction in various studies: some studies used the cadaver whole liver weight (1, 3, (5) (6) (7) ; some used a weighed living donor graft divided by the graft to the TLV ratio measured by CT volumetry (8, 12) ; whereas others used the total volume measured by the CT scan as the dependent variable for analysis. (2, 4, 11, 13, 14, 24) The hypothesis that a deceased donor liver weighs the same as a normal liver is questionable. A number of factors could influence the weight of a deceased donor liver, such as the disease that led to the donor's death, the effect of resuscitative therapy, the duration between circulatory arrest and autopsy examination or liver retrieval, (3) and the physiological changes secondary to brain death. (8) The method of using a partial liver weight from a living donor with a subsequent conversion to TLV of the donor as the dependent variable adds more variability on top of the CT measurement because there is always a discrepancy between the imaginary transection plane drawn by the radiologist and the actual transection plane that is made by the surgeon. Even though the erroneous estimation of liver volume is common because of the partial volume effect, respiratory artifacts, and difficulty in tracing to the periphery of liver especially over the left lobe edge, (25) the accuracy of CT volumetry has been validated by several studies (15, 26, 27) and is currently the most universally accepted method of volumetric liver assessment. Therefore, it should be an ideal reference for a linear regression analysis. Discrepancies between CT-anticipated GWs and the actual GWs at the back table could occur occasionally. Careful preoperative planning of the transection plane so as to provide a safety margin for both the donor and the recipient, preservation of venous outflow and improvement of outflow by venoplasty, and inclusion of the caudate lobe in the graft could help alleviate the problem of unexpected SFSGs.
The new formula was intended to provide a "normal reference" for an individual of specific anthropometric characteristics. Because a person could be born with a smaller or larger liver volume than he or she should have with respect to the body size, using CT-measured liver volume to determine the minimum future liver remnant is subject to error, especially in patients with liver cirrhosis. (28) This concept highlights the importance of ESLV because it tells how much liver a healthy donor could sacrifice based on the data from a large number of normal individuals. There is no role for a CT volumetric study in a patient with cirrhosis in the context of LT; the minimal graft size a transplant recipient requires in order to live is chiefly determined by the GRWR or ESLV. It is necessary for any formula derived from normal individuals to demonstrate accuracy also in the diseased population. Because hyperbilirubinemia and coagulopathy are the typical features of DGF resulting from SFSG after excluding secondary causes, the strongest association between GW/ESLV using the current formula and occurrence of DGF as demonstrated suggests that this formula is the most applicable to patients with cirrhosis when compared with the 4 other most often cited formulas in the literature and with GRWR prediction. Since the original description by Kiuchi et al., GRWR < 0.8% was considered to be an important criterion for the diagnosis of SFSS (29) ; however, from our analysis, the GRWR ratio had a weaker association with the SFSS surrogate than the newly derived formula.
There are a few limitations of the current study. First, the retrospective nature of the study would lead to confounders such as missing data, selection bias, and recall bias. Involvement of a large patient number with a random allocation of patients to the derivation group and the validation group would alleviate the problem. Second, the novel parameter using CTmeasured body thickness might not be applicable for patients with significant kyphoscoliosis. Third, the biochemical cutoff for delayed graft recovery as a SFSS surrogate could result in over/under diagnosis of such conditions. However, other clinical features of delayed graft recovery, such as hepatic encephalopathy and ascites, are more difficult to define. Therefore, the chosen surrogates were believed to be the most appropriate for the analysis in part 3 of the study. Last but not least, despite the large number of patients in this study (722 patients involved), there were only 40 patients (21 patients had preoperative CT scan done) found to have biochemical features of delayed graft recovery. For part 3 of the study, external validation of the formula with a larger number of patients would be beneficial. Nonetheless, the robustness of the statistical analysis with a large sample size, randomized population allocation, and formula validation by diseased transplant recipients marked the strengths of the study.
In conclusion, the new formula (2 3 thickness 1 10 3 weight 1 190) represents the first study proposing the use of CT-measured body thickness, which is novel, easy to use, and accurate for ESLV.
